Literature DB >> 28828925

Towards ion beam therapy based on laser plasma accelerators.

Leonhard Karsch1,2, Elke Beyreuther1, Wolfgang Enghardt1,2,3, Malte Gotz1,2, Umar Masood1,2, Ulrich Schramm1,4, Karl Zeil1, Jörg Pawelke1,2.   

Abstract

Only few ten radiotherapy facilities worldwide provide ion beams, in spite of their physical advantage of better achievable tumor conformity of the dose compared to conventional photon beams. Since, mainly the large size and high costs hinder their wider spread, great efforts are ongoing to develop more compact ion therapy facilities. One promising approach for smaller facilities is the acceleration of ions on micrometre scale by high intensity lasers. Laser accelerators deliver pulsed beams with a low pulse repetition rate, but a high number of ions per pulse, broad energy spectra and high divergences. A clinical use of a laser based ion beam facility requires not only a laser accelerator providing beams of therapeutic quality, but also new approaches for beam transport, dosimetric control and tumor conformal dose delivery procedure together with the knowledge of the radiobiological effectiveness of laser-driven beams. Over the last decade research was mainly focused on protons and progress was achieved in all important challenges. Although currently the maximum proton energy is not yet high enough for patient irradiation, suggestions and solutions have been reported for compact beam transport and dose delivery procedures, respectively, as well as for precise dosimetric control. Radiobiological in vitro and in vivo studies show no indications of an altered biological effectiveness of laser-driven beams. Laser based facilities will hardly improve the availability of ion beams for patient treatment in the next decade. Nevertheless, there are possibilities for a need of laser based therapy facilities in future.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28828925     DOI: 10.1080/0284186X.2017.1355111

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

1.  Biological effects in normal cells exposed to FLASH dose rate protons.

Authors:  Manuela Buonanno; Veljko Grilj; David J Brenner
Journal:  Radiother Oncol       Date:  2019-03-05       Impact factor: 6.280

2.  Ultra-High Dose-Rate, Pulsed (FLASH) Radiotherapy with Carbon Ions: Generation of Early, Transient, Highly Oxygenated Conditions in the Tumor Environment.

Authors:  Abdullah Muhammad Zakaria; Nicholas W Colangelo; Jintana Meesungnoen; Edouard I Azzam; Marc-Émile Plourde; Jean-Paul Jay-Gerin
Journal:  Radiat Res       Date:  2020-12-01       Impact factor: 2.841

Review 3.  Proton therapy for patients with esophageal cancer: History, characteristics, clinical outcome and future direction of proton beam therapy.

Authors:  Masataka Karube; Hidetsugu Nakayama
Journal:  Glob Health Med       Date:  2021-06-30

4.  The Importance and Clinical Implications of FLASH Ultra-High Dose-Rate Studies for Proton and Heavy Ion Radiotherapy.

Authors:  Nicholas W Colangelo; Edouard I Azzam
Journal:  Radiat Res       Date:  2019-10-28       Impact factor: 2.841

5.  Physics and biomedical challenges of cancer therapy with accelerated heavy ions.

Authors:  Marco Durante; Jürgen Debus; Jay S Loeffler
Journal:  Nat Rev Phys       Date:  2021-09-17

6.  Analysing Tumour Growth Delay Data from Animal Irradiation Experiments with Deviations from the Prescribed Dose.

Authors:  Leonhard Karsch; Elke Beyreuther; Doreen Eger Passos; Jörg Pawelke; Steffen Löck
Journal:  Cancers (Basel)       Date:  2019-08-31       Impact factor: 6.639

Review 7.  Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

Authors:  Joseph D Wilson; Ester M Hammond; Geoff S Higgins; Kristoffer Petersson
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.